StockMacro
Company, fund or insider

Help

Menu

Evolus

$6.52 +4.3% in 6 monthsMarket cap $431.5M

EOLS on XNAS, Health Care, Evolus, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue rose 13% to $78M in the latest quarter while short interest sits at 9.1% of shares.

  • GoodRevenue over 12 months up 14% to $325.5M
  • WatchNet loss of $31.1M over 12 months despite revenue growth

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Industry
Pharmaceutical preparations (Health Care)
Employees
365
Website
evolus.com
Listed
Nasdaq, US
Last results
4 Nov 2026
Next results
expected around 8 Jan 2027 (an estimate: a year ago it reported on 9 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $78.0M, net loss $12.5M.
Quarter to 31 Dec 2021: revenue $34.7M, net income -$18.2MQuarter to 31 Dec 2021: revenue $34.7M, net income -$18.2MQuarter to 31 Mar 2022: revenue $33.9M, net income -$17.5MQuarter to 31 Mar 2022: revenue $33.9M, net income -$17.5MQuarter to 30 Jun 2022: revenue $37.2M, net income -$23.5MQuarter to 30 Jun 2022: revenue $37.2M, net income -$23.5MQuarter to 30 Sep 2022: revenue $33.9M, net income -$20.3MQuarter to 30 Sep 2022: revenue $33.9M, net income -$20.3MQuarter to 31 Dec 2022: revenue $43.6M, net income -$13.2MQuarter to 31 Dec 2022: revenue $43.6M, net income -$13.2MQuarter to 31 Mar 2023: revenue $41.7M, net income -$14.8MQuarter to 31 Mar 2023: revenue $41.7M, net income -$14.8MQuarter to 30 Jun 2023: revenue $49.3M, net income -$18.1MQuarter to 30 Jun 2023: revenue $49.3M, net income -$18.1MQuarter to 30 Sep 2023: revenue $50.0M, net income -$16.9MQuarter to 30 Sep 2023: revenue $50.0M, net income -$16.9MQuarter to 31 Dec 2023: revenue $61.0M, net income -$11.8MQuarter to 31 Dec 2023: revenue $61.0M, net income -$11.8MQuarter to 31 Mar 2024: revenue $59.3M, net income -$13.1MQuarter to 31 Mar 2024: revenue $59.3M, net income -$13.1MQuarter to 30 Jun 2024: revenue $66.9M, net income -$11.3MQuarter to 30 Jun 2024: revenue $66.9M, net income -$11.3MQuarter to 30 Sep 2024: revenue $61.1M, net income -$19.2MQuarter to 30 Sep 2024: revenue $61.1M, net income -$19.2MQuarter to 31 Dec 2024: revenue $78.9M, net income -$6.8MQuarter to 31 Dec 2024: revenue $78.9M, net income -$6.8MQuarter to 31 Mar 2025: revenue $68.5M, net income -$18.9MQuarter to 31 Mar 2025: revenue $68.5M, net income -$18.9MQuarter to 30 Jun 2025: revenue $69.4M, net income -$17.1MQuarter to 30 Jun 2025: revenue $69.4M, net income -$17.1MQuarter to 30 Sep 2025: revenue $69.0M, net income -$15.7MQuarter to 30 Sep 2025: revenue $69.0M, net income -$15.7MQuarter to 31 Dec 2025: revenue $90.3M, net income $130KQuarter to 31 Dec 2025: revenue $90.3M, net income $130KQuarter to 31 Mar 2026: revenue $73.1M, net income -$10.7MQuarter to 31 Mar 2026: revenue $73.1M, net income -$10.7MQuarter to 30 Jun 2026: revenue $84.1M, net income -$8.1MQuarter to 30 Jun 2026: revenue $84.1M, net income -$8.1MQuarter to 30 Sep 2026: revenue $78.0M, net income -$12.5MQuarter to 30 Sep 2026: revenue $78.0M, net income -$12.5M
31 Dec 2021RevenueNet incomeNet losstallest bar $90.3M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$78.0M-$12.5M
30 Jun 2026$84.1M-$8.1M
31 Mar 2026$73.1M-$10.7M
31 Dec 2025$90.3M$130K
30 Sep 2025$69.0M-$15.7M
30 Jun 2025$69.4M-$17.1M
31 Mar 2025$68.5M-$18.9M
31 Dec 2024$78.9M-$6.8M
30 Sep 2024$61.1M-$19.2M
30 Jun 2024$66.9M-$11.3M
31 Mar 2024$59.3M-$13.1M
31 Dec 2023$61.0M-$11.8M
30 Sep 2023$50.0M-$16.9M
30 Jun 2023$49.3M-$18.1M
31 Mar 2023$41.7M-$14.8M
31 Dec 2022$43.6M-$13.2M
30 Sep 2022$33.9M-$20.3M
30 Jun 2022$37.2M-$23.5M
31 Mar 2022$33.9M-$17.5M
31 Dec 2021$34.7M-$18.2M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $325.5M $285.8M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +14% +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$31.1M -$58.6M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.47 -$0.91
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 66.4% 66.6% 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -4.8% -13.7% -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -9.6% -20.5% -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. – -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$4.9M -$52.7M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $41.7M $43.5M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $156.9M $145.8M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $115.2M $102.3M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.3 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.7 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. – 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
EvolusEOLS (this company) $431.5Mloss1.3+14%-9.6%
Indaptus TherapeuticsINDP $433.2Mloss–––
Aquestive TherapeuticsAQST $434.9Mloss8.9+13%-162%
ArvinasARVN $423.0Mloss1.5-12%-3.5%
ProthenaPRTA $422.1Mloss8.0+347%-45.4%
Capricor TherapeuticsCAPR $441.3Mloss–––

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+13%

$78.0M vs $69.0M (quarter ended 30 Sep 2026)

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$950K

bought $0, sold $950K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+9.1%

168 13F filers vs 154

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

76%

50.6M shares held by 13F filers (30 Sep 2026) of 66.2M outstanding (30 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

9.1%

6.0M shares sold short (30 Oct 2026) of 66.2M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

9.4

6.0M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-6.0%

6.4M shares sold short in the report before, 6.0M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

55%

55% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 52%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

5

5 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

5 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $6.52 on 20 Nov 2026, -1.5% over 12 months (12-month range $3.94 to $9.30)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $1.8M in the last 12 months (the 12 months before: -$3.5M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 1 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $78.0M in the latest quarter, +13% on a year earlier.
Capital spending per quarter. Capital spending $320K in the latest quarter, -66% on a year earlier.
Institutional holders (13F filers). 168 13F filers reported holding it in the latest 13F quarter, +8.4% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
13 Mar 20268-K and other filingsDirector or officer change
13 Mar 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Sep 20258-K and other filingsDirector or officer change
12 Aug 2025Sharp changeShort interest spike: short interest spike, 13.5M vs usual 6.0M (2025-07-31); 2.7x the same period a year earlier
5 Aug 20258-K and other filingsDirector or officer change
29 Jul 2025Sharp changeShort interest spike: short interest spike, 12.6M vs usual 5.7M (2025-07-15); 2.4x the same period a year earlier
1 Jul 2025Sharp changeShort interest spike: short interest spike, 10.6M vs usual 5.3M (2025-06-13); 2.3x the same period a year earlier
17 Jun 2025Sharp changeShort interest spike: short interest spike, 9.7M vs usual 5.3M (2025-05-30); 2.2x the same period a year earlier
6 Jun 20258-K and other filingsDirector or officer change
3 Jun 2025Sharp changeShort interest spike: short interest spike, 9.2M vs usual 5.2M (2025-05-15); 2.0x the same period a year earlier
27 May 20258-K and other filingsDirector or officer change
27 May 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 May 2025Sharp changeShort interest spike: short interest spike, 8.7M vs usual 5.2M (2025-04-30); 1.8x the same period a year earlier
29 Apr 2025Sharp changeShort interest spike: short interest spike, 7.7M vs usual 5.1M (2025-04-15); 1.7x the same period a year earlier
15 Apr 2025Sharp changeShort interest spike: short interest spike, 7.2M vs usual 5.0M (2025-03-31); 1.5x the same period a year earlier
1 Apr 2025Sharp changeShort interest spike: short interest spike, 7.1M vs usual 5.0M (2025-03-14); 1.4x the same period a year earlier
18 Mar 2025Sharp changeShort interest spike: short interest spike, 6.8M vs usual 5.0M (2025-02-28); 1.4x the same period a year earlier
1 Jul 20248-K and other filingsDirector or officer change
11 Jun 20248-K and other filingsDirector or officer change
3 Apr 20248-K and other filingsDirector or officer change
3 Apr 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Nov 2023Sharp changeShort interest spike: short interest spike, 6.5M vs usual 2.8M (2023-11-15); 2.8x the same period a year earlier
15 Aug 2023Sharp changeShort interest spike: short interest spike, 4.3M vs usual 2.4M (2023-07-31); 2.2x the same period a year earlier
1 Aug 2023Sharp changeShort interest spike: short interest spike, 4.4M vs usual 2.4M (2023-07-14); 2.0x the same period a year earlier
18 Jul 2023Sharp changeShort interest spike: short interest spike, 3.5M vs usual 2.3M (2023-06-30); 1.5x the same period a year earlier
10 Sep 2022Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 326K)
30 Aug 20228-K and other filingsDirector or officer change
30 Aug 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
4 Mar 20228-K and other filingsDirector or officer change
5 Jan 20228-K and other filingsDirector or officer change
5 Jan 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Mar 2022: -$702K published
Month from 1 May 2022: -$1.8M published
Month from 1 Aug 2022: -$345K published
Month from 1 Sep 2022: -$945K published
Month from 1 Oct 2022: -$406K published
Month from 1 Feb 2023: -$34.1M published
Month from 1 Mar 2023: -$722K published
Month from 1 Aug 2023: $1.1M published
Month from 1 Sep 2023: -$31K published
Month from 1 Oct 2023: -$12.7M published
Month from 1 Dec 2023: -$823K published
Month from 1 Feb 2024: -$305K published
Month from 1 Mar 2024: -$1.9M published
Month from 1 May 2024: -$772K published
Month from 1 Jun 2024: -$6.1M published
Month from 1 Sep 2024: -$138K published
Month from 1 Dec 2024: -$156K published
Month from 1 Mar 2025: -$2.2M published
Month from 1 May 2025: -$254K published
Month from 1 Jun 2025: -$1.1M published
Month from 1 Aug 2025: $162K published
Month from 1 Dec 2025: -$92K published
Month from 1 Mar 2026: -$797K published
Month from 1 Sep 2026: -$950K published
H-1B/E-3 applications certified
Quarter from 1 Jul 2023: 1 published
Quarter from 1 Apr 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $34.7M, +68% on a year earlier; public on 4 Mar 2022
Quarter ended 31 Mar 2022: $33.9M, +177% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $37.2M, +42% on a year earlier; public on 3 Aug 2022
Quarter ended 30 Sep 2022: $33.9M, +27% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $43.6M, +26% on a year earlier; public on 9 Mar 2023
Quarter ended 31 Mar 2023: $41.7M, +23% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $49.3M, +33% on a year earlier; public on 3 Aug 2023
Quarter ended 30 Sep 2023: $50.0M, +48% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $61.0M, +40% on a year earlier; public on 8 Mar 2024
Quarter ended 31 Mar 2024: $59.3M, +42% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $66.9M, +36% on a year earlier; public on 1 Aug 2024
Quarter ended 30 Sep 2024: $61.1M, +22% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $78.9M, +29% on a year earlier; public on 5 Mar 2025
Quarter ended 31 Mar 2025: $68.5M, +15% on a year earlier; public on 8 May 2025
Quarter ended 30 Jun 2025: $69.4M, +3.7% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $69.0M, +13% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $90.3M, +14% on a year earlier; public on 4 Mar 2026
Quarter ended 31 Mar 2026: $73.1M, +6.7% on a year earlier; public on 5 May 2026
Quarter ended 30 Jun 2026: $84.1M, +21% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $78.0M, +13% on a year earlier; public on 5 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $393K, +2212% on a year earlier; public on 4 Mar 2022
Quarter ended 31 Mar 2022: $12K; public on 11 May 2022
Quarter ended 30 Jun 2022: $231K; public on 3 Aug 2022
Quarter ended 30 Sep 2022: $509K; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $866K, +120% on a year earlier; public on 9 Mar 2023
Quarter ended 31 Mar 2023: $227K, +1792% on a year earlier; public on 10 May 2023
Quarter ended 30 Sep 2023: $29K, -94% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $209K, -76% on a year earlier; public on 8 Mar 2024
Quarter ended 31 Mar 2024: $256K, +13% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $465K; public on 1 Aug 2024
Quarter ended 30 Sep 2024: $313K, +979% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $438K, +110% on a year earlier; public on 5 Mar 2025
Quarter ended 31 Mar 2025: $319K, +25% on a year earlier; public on 8 May 2025
Quarter ended 30 Jun 2025: $688K, +48% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $955K, +205% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $1.5M, +238% on a year earlier; public on 4 Mar 2026
Quarter ended 31 Mar 2026: $415K, +30% on a year earlier; public on 5 May 2026
Quarter ended 30 Jun 2026: $50K, -93% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $320K, -66% on a year earlier; public on 5 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 94; public on 14 Feb 2022
31 Mar 2022 report: 109; public on 16 May 2022
30 Jun 2022 report: 114; public on 15 Aug 2022
30 Sep 2022 report: 119; public on 14 Nov 2022
31 Dec 2022 report: 109; public on 14 Feb 2023
31 Mar 2023 report: 118; public on 15 May 2023
30 Jun 2023 report: 126; public on 14 Aug 2023
30 Sep 2023 report: 129; public on 14 Nov 2023
31 Dec 2023 report: 142; public on 14 Feb 2024
31 Mar 2024 report: 160; public on 15 May 2024
30 Jun 2024 report: 149; public on 14 Aug 2024
30 Sep 2024 report: 160; public on 14 Nov 2024
31 Dec 2024 report: 162; public on 14 Feb 2025
31 Mar 2025 report: 173; public on 15 May 2025
30 Jun 2025 report: 162; public on 14 Aug 2025
30 Sep 2025 report: 155; public on 14 Nov 2025
31 Dec 2025 report: 163; public on 17 Feb 2026
31 Mar 2026 report: 143; public on 15 May 2026
30 Jun 2026 report: 154; public on 14 Aug 2026
30 Sep 2026 report: 168; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $950K (4 Sep 2026), 7.7× its normal reading; higher than 79% of its own history.
  • Insider net buying (open market): Insiders sold a net $1.8M in the last 12 months (the 12 months before: -$3.5M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 1 published in the last 12 months (none in the 12 months before).
  • Revenue per quarter: Revenue $78.0M in the latest quarter, +13% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 1 sale, $950K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
4 Sep 2026David MoatazediSee RemarksSell105,108$9.04$950KForm 4
20 Mar 2026Rui AvelarSee RemarksSell3,119$4.75$15KForm 4
20 Mar 2026David MoatazediSee RemarksSellplanned in advance (10b5-1)13,669$4.75$65KForm 4
18 Mar 2026David MoatazediSee RemarksSellplanned in advance (10b5-1); after exercising options116,720$4.89$571KForm 4
18 Mar 2026Rui AvelarSee RemarksSellplanned in advance (10b5-1); after exercising options29,996$4.89$147KForm 4
29 Dec 2025David MoatazediSee RemarksSellplanned in advance (10b5-1)10,539$7.15$75KForm 4
29 Dec 2025Rui AvelarSee RemarksSellplanned in advance (10b5-1)2,261$7.15$16KForm 4
26 Aug 2025Tomoko Yamagishi-DresslerChief Marketing OfficerSellplanned in advance (10b5-1)5,722$7.51$43KForm 4

168 institutions reported shares at the end of Q3 2026, 76% of the shares outstanding; 29 opened a position, 18 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Nantahala Capital Management, LLC6.2M9.43%$50.0M-5.0M-44%
BlackRock, Inc.5.3M8.03%$42.5M+475K+9.8%
Soleus Capital Management, L.P.5.1M7.69%$40.7M+4.3M+519%
Braidwell LP3.1M4.66%$24.7M-71K-2.3%
Frazier Life Sciences Management, L.P.2.6M3.97%$21.0MNo change
Perceptive Advisors LLC2.5M3.72%$19.7MNo change
Vanguard Capital Management LLC2.3M3.42%$18.1M-102K-4.3%
State Street Corp1.9M2.80%$14.8M+157K+9.2%
Millennium Management LLC1.7M2.49%$13.2M-138K-7.7%
Geode Capital Management, LLC1.6M2.39%$12.6M-28K-1.7%

Company events

All 48 company events

In 12 months: 3 major agreements, 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
4 Aug 2026Signed a major agreement8-K
8 Jul 2026Signed a major agreement8-K
13 Mar 2026Director or officer change8-K
3 Mar 2026Signed a major agreementSame filing: took on new debt8-K
8 Sep 2025Director or officer change8-K
5 Aug 2025Director or officer change8-K
6 Jun 2025Director or officer changeSame filing: shareholder vote results8-K
27 May 2025Director or officer change8-K

Reported lobbying spend: $35K in Q1 2021, $105K in Q4 2020. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Feb 2021EndedCarmen Group Incorporatedfor Evolus IncUSITC 337 reviewTradeFiling
10 Sep 2020NewCarmen Group Incorporatedfor Evolus IncUSITC 337 reviewTradeFiling

The 5 newest of 74 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 13 Mar 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 13 Mar 2026Filings record

    Director or officer change

  3. 8 Sep 2025Filings record

    Director or officer change

  4. 19 Aug 2025Insiders record

    Stewart Brady (director) bought 30,000 shares of EOLS ($204,600) (dated 18 Aug 2025)

  5. 12 Aug 2025Short interest and volume change

    had 13.5M shares sold short in the 31 Jul 2025 report, 2.7× the same report last year.

    Same report last year: 5.0M; its normal report is 6.0M.

    See the evidence
    This period
    13.5M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    6.0M
    Typical spread (median absolute deviation)
    1.1M
    How far from its usual level
    +4.7
    Same report last year
    5.0M
    History used
    2,723 days
    2024-07-31: 5.0M2024-08-15: 4.8M2024-08-30: 4.8M2024-09-13: 4.9M2024-09-30: 4.8M2024-10-15: 5.0M2024-10-31: 5.4M2024-11-15: 5.3M2024-11-29: 5.2M2024-12-13: 5.2M2024-12-31: 5.4M2025-01-15: 5.9M2025-01-31: 6.0M2025-02-14: 6.6M2025-02-28: 6.8M2025-03-14: 7.1M2025-03-31: 7.2M2025-04-15: 7.7M2025-04-30: 8.7M2025-05-15: 9.2M2025-05-30: 9.7M2025-06-13: 10.6M2025-06-30: 12.0M2025-07-15: 12.6M2025-07-31: 13.5M
    the 31 Jul 2025 report24 earlier reportsnormal: 6.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 5 Aug 2025Filings record

    Director or officer change

  7. 25 Jul 2025Short interest and volume change

    had 12.6M shares sold short in the 15 Jul 2025 report, 2.4× the same report last year.

    Same report last year: 5.3M; its normal report is 5.7M.

    See the evidence
    This period
    12.6M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    5.7M
    Typical spread (median absolute deviation)
    851K
    How far from its usual level
    +5.5
    Same report last year
    5.3M
    History used
    2,707 days
    2024-07-15: 5.3M2024-07-31: 5.0M2024-08-15: 4.8M2024-08-30: 4.8M2024-09-13: 4.9M2024-09-30: 4.8M2024-10-15: 5.0M2024-10-31: 5.4M2024-11-15: 5.3M2024-11-29: 5.2M2024-12-13: 5.2M2024-12-31: 5.4M2025-01-15: 5.9M2025-01-31: 6.0M2025-02-14: 6.6M2025-02-28: 6.8M2025-03-14: 7.1M2025-03-31: 7.2M2025-04-15: 7.7M2025-04-30: 8.7M2025-05-15: 9.2M2025-05-30: 9.7M2025-06-13: 10.6M2025-06-30: 12.0M2025-07-15: 12.6M
    the 15 Jul 2025 report24 earlier reportsnormal: 5.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 26 Jun 2025Short interest and volume change

    had 10.6M shares sold short in the 13 Jun 2025 report, 2.3× the same report last year.

    Same report last year: 4.5M; its normal report is 5.3M.

    See the evidence
    This period
    10.6M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    5.3M
    Typical spread (median absolute deviation)
    582K
    How far from its usual level
    +6.1
    Same report last year
    4.5M
    History used
    2,675 days
    2024-06-14: 4.5M2024-06-28: 4.8M2024-07-15: 5.3M2024-07-31: 5.0M2024-08-15: 4.8M2024-08-30: 4.8M2024-09-13: 4.9M2024-09-30: 4.8M2024-10-15: 5.0M2024-10-31: 5.4M2024-11-15: 5.3M2024-11-29: 5.2M2024-12-13: 5.2M2024-12-31: 5.4M2025-01-15: 5.9M2025-01-31: 6.0M2025-02-14: 6.6M2025-02-28: 6.8M2025-03-14: 7.1M2025-03-31: 7.2M2025-04-15: 7.7M2025-04-30: 8.7M2025-05-15: 9.2M2025-05-30: 9.7M2025-06-13: 10.6M
    the 13 Jun 2025 report24 earlier reportsnormal: 5.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 11 Jun 2025Short interest and volume change

    had 9.7M shares sold short in the 30 May 2025 report, 2.2× the same report last year.

    Same report last year: 4.4M; its normal report is 5.3M.

    See the evidence
    This period
    9.7M (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    5.3M
    Typical spread (median absolute deviation)
    512K
    How far from its usual level
    +5.8
    Same report last year
    4.4M
    History used
    2,661 days
    2024-05-31: 4.4M2024-06-14: 4.5M2024-06-28: 4.8M2024-07-15: 5.3M2024-07-31: 5.0M2024-08-15: 4.8M2024-08-30: 4.8M2024-09-13: 4.9M2024-09-30: 4.8M2024-10-15: 5.0M2024-10-31: 5.4M2024-11-15: 5.3M2024-11-29: 5.2M2024-12-13: 5.2M2024-12-31: 5.4M2025-01-15: 5.9M2025-01-31: 6.0M2025-02-14: 6.6M2025-02-28: 6.8M2025-03-14: 7.1M2025-03-31: 7.2M2025-04-15: 7.7M2025-04-30: 8.7M2025-05-15: 9.2M2025-05-30: 9.7M
    the 30 May 2025 report24 earlier reportsnormal: 5.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 11 Jun 2025Insiders record

    White Albert G III (director) bought 20,000 shares of EOLS ($189,000) (dated 10 Jun 2025)

  11. 6 Jun 2025Filings record

    Director or officer change

  12. 28 May 2025Short interest and volume change

    had 9.2M shares sold short in the 15 May 2025 report, 2.0× the same report last year.

    Same report last year: 4.6M; its normal report is 5.2M.

    See the evidence
    This period
    9.2M (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    5.2M
    Typical spread (median absolute deviation)
    472K
    How far from its usual level
    +5.7
    Same report last year
    4.6M
    History used
    2,646 days
    2024-05-15: 4.6M2024-05-31: 4.4M2024-06-14: 4.5M2024-06-28: 4.8M2024-07-15: 5.3M2024-07-31: 5.0M2024-08-15: 4.8M2024-08-30: 4.8M2024-09-13: 4.9M2024-09-30: 4.8M2024-10-15: 5.0M2024-10-31: 5.4M2024-11-15: 5.3M2024-11-29: 5.2M2024-12-13: 5.2M2024-12-31: 5.4M2025-01-15: 5.9M2025-01-31: 6.0M2025-02-14: 6.6M2025-02-28: 6.8M2025-03-14: 7.1M2025-03-31: 7.2M2025-04-15: 7.7M2025-04-30: 8.7M2025-05-15: 9.2M
    the 15 May 2025 report24 earlier reportsnormal: 5.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 27 May 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 27 May 2025Filings record

    Director or officer change

  15. 10 May 2025Short interest and volume change

    had 8.7M shares sold short in the 30 Apr 2025 report, 1.8× the same report last year.

    Same report last year: 4.8M; its normal report is 5.2M.

    See the evidence
    This period
    8.7M (the 30 Apr 2025 report)
    Normal report (median of 24 earlier)
    5.2M
    Typical spread (median absolute deviation)
    426K
    How far from its usual level
    +5.6
    Same report last year
    4.8M
    History used
    2,631 days
    2024-04-30: 4.8M2024-05-15: 4.6M2024-05-31: 4.4M2024-06-14: 4.5M2024-06-28: 4.8M2024-07-15: 5.3M2024-07-31: 5.0M2024-08-15: 4.8M2024-08-30: 4.8M2024-09-13: 4.9M2024-09-30: 4.8M2024-10-15: 5.0M2024-10-31: 5.4M2024-11-15: 5.3M2024-11-29: 5.2M2024-12-13: 5.2M2024-12-31: 5.4M2025-01-15: 5.9M2025-01-31: 6.0M2025-02-14: 6.6M2025-02-28: 6.8M2025-03-14: 7.1M2025-03-31: 7.2M2025-04-15: 7.7M2025-04-30: 8.7M
    the 30 Apr 2025 report24 earlier reportsnormal: 5.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 26 Apr 2025Short interest and volume change

    had 7.7M shares sold short in the 15 Apr 2025 report, 1.7× the same report last year.

    Same report last year: 4.6M; its normal report is 5.1M.

    See the evidence
    This period
    7.7M (the 15 Apr 2025 report)
    Normal report (median of 24 earlier)
    5.1M
    Typical spread (median absolute deviation)
    338K
    How far from its usual level
    +5.0
    Same report last year
    4.6M
    History used
    2,616 days
    2024-04-15: 4.6M2024-04-30: 4.8M2024-05-15: 4.6M2024-05-31: 4.4M2024-06-14: 4.5M2024-06-28: 4.8M2024-07-15: 5.3M2024-07-31: 5.0M2024-08-15: 4.8M2024-08-30: 4.8M2024-09-13: 4.9M2024-09-30: 4.8M2024-10-15: 5.0M2024-10-31: 5.4M2024-11-15: 5.3M2024-11-29: 5.2M2024-12-13: 5.2M2024-12-31: 5.4M2025-01-15: 5.9M2025-01-31: 6.0M2025-02-14: 6.6M2025-02-28: 6.8M2025-03-14: 7.1M2025-03-31: 7.2M2025-04-15: 7.7M
    the 15 Apr 2025 report24 earlier reportsnormal: 5.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 10 Apr 2025Short interest and volume change

    had 7.2M shares sold short in the 31 Mar 2025 report, 1.5× the same report last year.

    Same report last year: 4.6M; its normal report is 5.0M.

    See the evidence
    This period
    7.2M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    320K
    How far from its usual level
    +4.3
    Same report last year
    4.6M
    History used
    2,601 days
    2024-03-28: 4.6M2024-04-15: 4.6M2024-04-30: 4.8M2024-05-15: 4.6M2024-05-31: 4.4M2024-06-14: 4.5M2024-06-28: 4.8M2024-07-15: 5.3M2024-07-31: 5.0M2024-08-15: 4.8M2024-08-30: 4.8M2024-09-13: 4.9M2024-09-30: 4.8M2024-10-15: 5.0M2024-10-31: 5.4M2024-11-15: 5.3M2024-11-29: 5.2M2024-12-13: 5.2M2024-12-31: 5.4M2025-01-15: 5.9M2025-01-31: 6.0M2025-02-14: 6.6M2025-02-28: 6.8M2025-03-14: 7.1M2025-03-31: 7.2M
    the 31 Mar 2025 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 26 Mar 2025Short interest and volume change

    had 7.1M shares sold short in the 14 Mar 2025 report, 1.4× the same report last year.

    Same report last year: 5.0M; its normal report is 5.0M.

    See the evidence
    This period
    7.1M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    291K
    How far from its usual level
    +4.2
    Same report last year
    5.0M
    History used
    2,584 days
    2024-03-15: 5.0M2024-03-28: 4.6M2024-04-15: 4.6M2024-04-30: 4.8M2024-05-15: 4.6M2024-05-31: 4.4M2024-06-14: 4.5M2024-06-28: 4.8M2024-07-15: 5.3M2024-07-31: 5.0M2024-08-15: 4.8M2024-08-30: 4.8M2024-09-13: 4.9M2024-09-30: 4.8M2024-10-15: 5.0M2024-10-31: 5.4M2024-11-15: 5.3M2024-11-29: 5.2M2024-12-13: 5.2M2024-12-31: 5.4M2025-01-15: 5.9M2025-01-31: 6.0M2025-02-14: 6.6M2025-02-28: 6.8M2025-03-14: 7.1M
    the 14 Mar 2025 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 12 Mar 2025Short interest and volume change

    had 6.8M shares sold short in the 28 Feb 2025 report, 1.4× the same report last year.

    Same report last year: 5.0M; its normal report is 5.0M.

    See the evidence
    This period
    6.8M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    263K
    How far from its usual level
    +3.7
    Same report last year
    5.0M
    History used
    2,570 days
    2024-02-29: 5.0M2024-03-15: 5.0M2024-03-28: 4.6M2024-04-15: 4.6M2024-04-30: 4.8M2024-05-15: 4.6M2024-05-31: 4.4M2024-06-14: 4.5M2024-06-28: 4.8M2024-07-15: 5.3M2024-07-31: 5.0M2024-08-15: 4.8M2024-08-30: 4.8M2024-09-13: 4.9M2024-09-30: 4.8M2024-10-15: 5.0M2024-10-31: 5.4M2024-11-15: 5.3M2024-11-29: 5.2M2024-12-13: 5.2M2024-12-31: 5.4M2025-01-15: 5.9M2025-01-31: 6.0M2025-02-14: 6.6M2025-02-28: 6.8M
    the 28 Feb 2025 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 1 Jul 2024Filings record

    Director or officer change

  21. 11 Jun 2024Filings record

    Director or officer change

  22. 3 Apr 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 3 Apr 2024Filings record

    Director or officer change

  24. 28 Nov 2023Short interest and volume change

    had 6.5M shares sold short in the 15 Nov 2023 report, 2.8× the same report last year.

    Same report last year: 2.3M; its normal report is 2.8M.

    See the evidence
    This period
    6.5M (the 15 Nov 2023 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    569K
    How far from its usual level
    +4.4
    Same report last year
    2.3M
    History used
    2,099 days
    2022-11-15: 2.3M2022-11-30: 2.3M2022-12-15: 1.9M2022-12-30: 2.6M2023-01-13: 2.6M2023-01-31: 2.2M2023-02-15: 2.4M2023-02-28: 2.2M2023-03-15: 2.2M2023-03-31: 2.4M2023-04-14: 2.5M2023-04-28: 2.8M2023-05-15: 2.8M2023-05-31: 2.8M2023-06-15: 3.0M2023-06-30: 3.5M2023-07-14: 4.4M2023-07-31: 4.3M2023-08-15: 3.4M2023-08-31: 3.4M2023-09-15: 3.6M2023-09-29: 3.8M2023-10-13: 3.9M2023-10-31: 4.1M2023-11-15: 6.5M
    the 15 Nov 2023 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 16 Aug 2023Insiders record

    Malik Vikram (director) bought 174,967 shares of EOLS ($1.3M) (dated 15 Aug 2023)

  26. 10 Aug 2023Short interest and volume change

    had 4.3M shares sold short in the 31 Jul 2023 report, 2.2× the same report last year.

    Same report last year: 2.0M; its normal report is 2.4M.

    See the evidence
    This period
    4.3M (the 31 Jul 2023 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    241K
    How far from its usual level
    +5.5
    Same report last year
    2.0M
    History used
    1,992 days
    2022-07-29: 2.0M2022-08-15: 2.1M2022-08-31: 2.1M2022-09-15: 1.9M2022-09-30: 2.2M2022-10-14: 2.7M2022-10-31: 2.6M2022-11-15: 2.3M2022-11-30: 2.3M2022-12-15: 1.9M2022-12-30: 2.6M2023-01-13: 2.6M2023-01-31: 2.2M2023-02-15: 2.4M2023-02-28: 2.2M2023-03-15: 2.2M2023-03-31: 2.4M2023-04-14: 2.5M2023-04-28: 2.8M2023-05-15: 2.8M2023-05-31: 2.8M2023-06-15: 3.0M2023-06-30: 3.5M2023-07-14: 4.4M2023-07-31: 4.3M
    the 31 Jul 2023 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 26 Jul 2023Short interest and volume change

    had 4.4M shares sold short in the 14 Jul 2023 report, 2.0× the same report last year.

    Same report last year: 2.2M; its normal report is 2.4M.

    See the evidence
    This period
    4.4M (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    219K
    How far from its usual level
    +6.3
    Same report last year
    2.2M
    History used
    1,975 days
    2022-07-15: 2.2M2022-07-29: 2.0M2022-08-15: 2.1M2022-08-31: 2.1M2022-09-15: 1.9M2022-09-30: 2.2M2022-10-14: 2.7M2022-10-31: 2.6M2022-11-15: 2.3M2022-11-30: 2.3M2022-12-15: 1.9M2022-12-30: 2.6M2023-01-13: 2.6M2023-01-31: 2.2M2023-02-15: 2.4M2023-02-28: 2.2M2023-03-15: 2.2M2023-03-31: 2.4M2023-04-14: 2.5M2023-04-28: 2.8M2023-05-15: 2.8M2023-05-31: 2.8M2023-06-15: 3.0M2023-06-30: 3.5M2023-07-14: 4.4M
    the 14 Jul 2023 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 13 Jul 2023Short interest and volume change

    had 3.5M shares sold short in the 30 Jun 2023 report, 1.5× the same report last year.

    Same report last year: 2.4M; its normal report is 2.3M.

    See the evidence
    This period
    3.5M (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    2.3M
    Typical spread (median absolute deviation)
    207K
    How far from its usual level
    +3.9
    Same report last year
    2.4M
    History used
    1,961 days
    2022-06-30: 2.4M2022-07-15: 2.2M2022-07-29: 2.0M2022-08-15: 2.1M2022-08-31: 2.1M2022-09-15: 1.9M2022-09-30: 2.2M2022-10-14: 2.7M2022-10-31: 2.6M2022-11-15: 2.3M2022-11-30: 2.3M2022-12-15: 1.9M2022-12-30: 2.6M2023-01-13: 2.6M2023-01-31: 2.2M2023-02-15: 2.4M2023-02-28: 2.2M2023-03-15: 2.2M2023-03-31: 2.4M2023-04-14: 2.5M2023-04-28: 2.8M2023-05-15: 2.8M2023-05-31: 2.8M2023-06-15: 3.0M2023-06-30: 3.5M
    the 30 Jun 2023 report24 earlier reportsnormal: 2.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 7 Feb 2023Insiders record

    Medytox Inc. (ten percent owner) bought 37,043 shares of EOLS ($408,788) (dated 6 Feb 2023)

  30. 14 Sep 2022Insiders record

    HAYMAN ROBERT (director) bought 10,000 shares of EOLS ($103,969) (dated 13 Sep 2022)

  31. 14 Sep 2022Insiders record

    HAYMAN ROBERT (director) bought 5,000 shares of EOLS ($50,250) [amended] (dated 13 Sep 2022)

  32. 10 Sep 2022Insiders change

    had 3 insiders buy $326K of its shares on the open market within 30 days (3 filings).

    Who bought: Farrell Peter C, Blank Simone, Hayman Robert.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $326K
    Window
    11 Aug 2022 to 10 Sep 2022

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  33. 10 Sep 2022Insiders record

    HAYMAN ROBERT (director) bought 4,967 shares of EOLS ($49,918) (dated 9 Sep 2022)

  34. 9 Sep 2022Insiders record

    BLANK SIMONE (director) bought 20,000 shares of EOLS ($184,800) (dated 8 Sep 2022)

  35. 7 Sep 2022Insiders record

    FARRELL PETER C (director) bought 10,000 shares of EOLS ($91,000) (dated 6 Sep 2022)

  36. 30 Aug 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  37. 30 Aug 2022Filings record

    Director or officer change

  38. 4 Mar 2022Filings record

    Director or officer change

  39. 5 Jan 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  40. 5 Jan 2022Filings record

    Director or officer change

Showing the newest 40 of 92 entries; narrow the window or the kind of data to see older ones.

Not listed: 204 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001570562
Ticker
EOLS
Domain
evolus.com
Employer name
Evolus, Inc. (1 unverified)
Hq location
CA|NEWPORT BEACH|92660 (1 unverified)
Lobbying client
evolus
Name
Evolus Australia Pty Ltd, Evolus, Inc., Evolus International Ltd, Evolus New Zealand Limited and 2 more
  • DOL H-1B labor condition applications and PERM certifications11 data points19 Jun 2023 to 23 Feb 2026
  • Federal lobbying disclosures (LDA)2 records, 9 data points10 Sep 2020 to 31 Mar 2021
  • SEC Form 13F institutional holdings315 data points31 Mar 2018 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)145 records8 Jan 2018 to 4 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)676 data points31 Dec 2016 to 30 Oct 2026
  • SEC Form 4 insider transactions120 records, 288 data points4 Jun 2018 to 4 Sep 2026
  • FINRA short interest (twice monthly)614 data points15 Feb 2018 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026